2022-03-31-accounts

			Page
Chairman's	report
Trustees'	annual report		2-9
Auditors'	report		10-12
Statement	offinancial	activities	13
Balance sheet			14
Statement	ofcashflaws		15-16
Notes to the financial		statements	17-29

Castel Froma Neuro	Castel Froma Neuro	Castel Froma Neuro	Care	Limited:—
Registered	charity number				1100965
Registered	company		number		04777559
Country of	incorporation				England
Royal Midland		Counties		Home for the
Disabled registered			charity number
(Linked charity)					1100965-1
Registered	office				93 Lillington Road
					Leamington Spa
					Warwickshire
					CV32 6LL
Auditors					Harrison Beale 5 Owen		Limited
					Chartered Accountants		and Statutory Auditor
					Highdown House,
					11Highdown	Road
					Leamington Spa
					CV31 1XT
Bankers					LIoyds Bank
					73The Parade
					Leamington Spa
					CV32 4BB
Solicitors					Wright Hassall	LLP
					Olympus Avenue
					Leamington Spa
					CV34 6BF
					Harrison Clark	Rickerbys	Limited
					Ellenborough	House
					Wellington Street
					Cheltenham
					Gloucestershire
					GL50 1YD

Directors	Directors	and	truste	es and officials
President					12'"Earl ofAylesford
Patron					Mr TCox, Her Majesty's		Lord Lieutenant					ofWarwickshire
Vice-President					Mrs D Dowdeswell OBE
Trustees					Dr C Wilson (Chairman)
					Mr G Murrell (Vice-Chairman)
					Mr SJ Nicklin
					Mrs L Holiday
					Mr D Leigh-Hunt
					Dr D Stableforth
					Mr J Evison
Ex-Off
					Ms E CJackman (resigned			5July	2022)
					Mrs A J Ford (appointed		18January 2022; resigned 4 October 2022)
					Mr CWade (appointed		18January 2022;					resigned 10October 2022)
	cio				The Chairman ofWarwick			District Council
					His Worship the Mayor		of	Royal	Leamington				Spa
Senior	Management			Team	Mrs M Bawden (Chief Executive				gi Nominated				individual)
					Mrs EJackson (Deputy	Chief Executive)
					Mr A Albu (Registered	Manager,			Lillington			House)
					Mrs S Hook (Registered		Manager,		Helen		Ley		House)
					Mr S CTaylor (Consultant			to the	Board	—resigned 31July 2022)
					Ms K Grove (Clinical Compliance				manager)
					Ms K Gates (Therapy manager)
Company		Secretary			Mrs A M Stiles (resigned		30 November			2022)
					Mrs M Bawden (appointed			30 November				2022)
Care Standards			Committee		Mrs L Holiday (Chair)
					Dr C Wilson
					Mr G Murrell
					Dr D Stableforth
					Mr S Nicklin
Finance, Assets			gi Risk Committee
(including		profiling R fundraising)			Mr G Murrell (Chair)
					Dr C Wilson
					Mr J Evison
					Mr D Leigh-Hunt
					Mrs L Holiday
					Mr S Nicklin
					Dr D Stableforth
Remuneration			Committee		Mr D Leigh-Hunt (Chair)
					Dr C Wilson
					Mrs L Holiday
					Mr J Evison
					Mr S Nicklin
					Mr G Murrell

			Unrestricted	Restricted	and	Total	Total
			Funds	Endowment		2022	2021
				Funds
					E
Income and endowments	from:
Donations and legacies			77,792			77,792	229,067
Charitable activities
Operation ofcare centres:
Residential fees			6,908,509			6,908,509	7,050,647
Hydrotherapy			18,640			18,640	23,258
Government grants			207,110			207,110	347,539
Investments		3	179,521			179,521	173,669
Other		2	6,324			6,324	25,226
Total income and endowments		2	7,397,896			7,397,896	7,849,406
Expenditure on:
Raising funds			49,487			49,487	67,144
Charitable activities:
Operation ofcare centres		9	7,699,456			7,699,456	8,480,505
Total expenditure			7,748,943			7,748,943	8,547,649
Net (expenditure)/ income		7	(351,047)			(351,047)	(698,243)
Transfers between funds		19
Other recognised gains/ (losses):
Other gains/ (losses)			(2,957)			(2,957)	430,784
Net movement in funds			(354,004)			(354,004)	(267,459)
Reconciliation offunds
Total fund balances brought	forward
at 1April 2021		19	7,151,881	4,325,033		11,476,914	11,744,373
Total fund balances carried	forward
at 31March 2022			6 797 377	4 323033		~1122910	~22 4 6914

		BALANCE SHEETAS AT31MARCH 2022	BALANCE SHEETAS AT31MARCH 2022
				2022	2021
					E
			Note
Fixed assets
Tangible assets			10	7,978,016	8,067,914
Investments			11	3,106,778	3,014,784
				11,084,794	11,082,698
Current assets
Stock			12	117,267	177,397
Debtors			13	494,318	309,344
Cash at bank and in	hand			586,529	1,150,664
				1,198,114	1,637,405
Creditors: amounts	falling due within one year		14	(595,565)	(645,867)
Net current assets				602,549	991,538
Total assets less current		liabilities		11,687,343	12,074,236
Creditors; amounts	falling due in more than one		15	(564,433)	(597,322)
year
Net assets				11,122,910	11,476,914
Unrestricted funds
General funds
General			19	2,965,224	3,260,186
Fair value reserve			19	700,000	700,000
Total General funds				3,665,224	3,960,186
Designated funds			19	3,132,653	3,191,695
				6,797,877	7,151,881
Restricted funds				75,033	75,033
Endowment fund			19	4,250,000	4,250,000
(held by Castel Froma	Neuro Care Ltd as a trustee of RMCHD)
				11,122,910	11,476,914

						2022	2021
						f	f
				Note
Cash (used in)/ provided	by operating		activities			(363,541)	689,256
Cash flows from investing	activities
Payments to acquire tangible fixed assets						(235,893)	(139,416)
Payments to acquire fixed asset investments						(97,948)	(219,968)
Receipts from disposal offixed asset investments							30,300
Interest received						3,585	1,569
Rents received from investment		properties				175,936	172,100
Cash used in investing activities						(154,320)	(155,415)
Cash flows from financing	activities
Repayment oflong-term	loans					(30,856)	(27,696)
Interest paid						(18,415)	(19,201)
Cash used in financing activities						(49,271)	(46,897)
(Decrease)/ Increase in cash and						(567,132)	486,944
cash equivalents
Cash and cash equivalents	at 1April					1,162,958	676,014
Cash and cash equivalents	at 31	March				595,826	1,162,958
Cash and cash equivalents	consists of:
Cash at bank and in hand						586,529	1,150,664
Listed investments cash						9,297	12,294
Cash and cash equivalents	at 31March					595,826	1,162,958
Analysis ofchanges in net	funds
				At 1			At 31
				April	Cash	Non-cash	March
				2021	flows	changes	2022
				f	f	f	f
Long term loans				(597,322)		32,889	(564,433)
Short term loans				(28,897)	30,856	(32,889)	(30,930)
Total liabilities				(626,219)	30,856		(595,363)
Cash and cash equivalents				1,162,958	(567,132)		595,826
Total net funds				536,739	(536,276)		463

					2022	2021
					f	E
Net movement in funds					(354,004)	(267,459)
Rents received from	investment		properties		(175,936)	(172,100)
Interest receivable					(3,585)	(1,569)
Interest payable					18,415	19,201
Depreciation and impairment		of	tangible fixed assets		325,791	900,146
Losses/ (Gains) on investments					2,957	(430,784)
Decrease/ (Increase)	in stock				60,130	(105,681)
(Increase)/ Decrease	in debtors				(184,974)	573,886
(Decrease)/ Increase	in creditors				(52,335)	173,616
Net cash (used in)/	provided	by	operating	activities	(363,541)	689,256

Expenditure on raising	funds
										2022				2021
										f				f
Professional fees for direct fundraising			costs							14,213				30,287
Professional fees for investing activities										8,633				5,187
Property management	fees and	repairs								8,226				12,469
Bank loan interest										18,415				19,201
										49,487				67,144
Ofthe expenditure on	raising funds above,			only f14,213(2021:f30,287) related				directly to			donations		and lega		c
income in the financial	statements. Other expenditure is associated					with professional				and property		management
fees in respect of fixed	asset investments			and investment	property;	and the cost				of servicing secured				loans
disclosed in note 15.
All expenditure on raising funds		in the current and prior year was attributable					to	unrestricted			funds.
Staff costs, trustee remuneration		and expenses and the cost ofkey
management personnel
										2022				2021
										f				f
Wages and salaries								5,073,987				5,085,850
Social security costs									402,634				372,109
Pensions										97,575			104,923
								5,574,196				5,562,882
Wages and salaries include agency staff			costs totalling f343,117(2021:f264,				104).
The trustees neither received nor		waived any		remuneration	during the	year (2021:ENil). No trustee was							reimbursed
expenses during the current or prior year.
The number ofstaff whose emoluments			fell	within the following						No.			No.
bands was as follows:—
E60,001tof70,000
f70,001tof80,000
E110,001to f120,000

equivalent employees (including part time staff) d	uring the year was:
	2022
	No.
Management	6	5
Administration	6	7
Nursing	31	34
Ancillary care	83	84
Therapy	21	20
Housekeeping	14	15
Services	5	4
	166	169

Net expendit	ure/ i	nco	me
						2022	2021
						f	E
Net (expenditure)/		income		is stated after charging/	(crediting);-
Other operating leases						38,436	41,017
Depreciation	—owned		assets			325,791	389,726
Impairment	loss —owned assets						510,420
Government	grants	—CJRS					(18,543)
Government	grants	—Other				(207,110)	(328,996)
Income from	operating		lease arrangements			(175,936)	(172,100)
Auditors' remuneration						8,000	8,000
Interest payable
						2022	2021
						E	f
Bank loan Interest						18,415	19,201

					Operation
					of Care		Total	Total
					centres	Thera pies	2022	2021
					f	f	f		'!
Staff					3,968,827	617,875	4,586,702	4,657,614
Rent & rates					26,452	3,607	30,059	29,251
Light, heat & power					120,708	16,460	137,168	140,298
Supplies (medical, catering &cleaning)					376,095	51,286	427,381	440,205
Repairs & maintenance					205,370	28,005	233,375	218,868
Training					22,189	3,026	25,215	22,677
Subscriptions					58,559	7,985	66,544	50,521
Motor & travelling	expenses				8,571	1,169	9,740	10,429
Insurance					88,349	12,048	100,397	81,977
Bank charges &interest					1,522		1,522	1,606
Depreciation					293,208	32,579	325,787	389,726
Impairment								510,420
General expenses					90,787	32,851	123,638	87,707
Covid-19 expenses					220,075	30,010	250,085	575,642
					5,480,712	836,901	6,317,613	7,216,941
					Operation
Allocation ofsupport		and governance		costs	ofCare
to activities					centres		Total	Total
							2022	2021
					f		f	f
Wages and salaries	&	related costs			887,158		887,158	843,620
(allocated on time)
General					150,124		150,124	130,180
(pro rata to staff full	time equivalent)
Legal and other professional fees					137,564		137,564	136,411
Support costs					1,174,846		1,174,846	1,110,211
Governance costs					206,997		206,997	153,353
(allocated on time)
Direct costs							6,317,613	7,216,941
Total costs relating to the operation			of	the care centres			7,699,456	8,480,505
Governance costs comprise the following:—
							2022	2021
							f	f
Staff costs							100,336	61,648
Legal and professional		fees					106,661	91,705
							206,997	153,353

Stock
			2022	2021
			f	E
Domestic supplies		and consumables	117,267	177,397
Debtors
			2022	2021
			f	E
Trade debtors			287,060	114,017
Other debtors				850
Prepayments	and	accrued income	207,258	194,477
			494,318	309,344

			2022	2021
			f	E
Bank loans and	overdraft		30,930	28,897
Trade creditors			217,244	242,031
Accruals and deferred		income	220,368	244,066
Other taxation	and social security		100,270	100,228
Other creditors			26,753	30,645
			595,565	645,867

Credi	tors: amounts falling due in more than	one year
		2022	2021
		E	E
Bank	loans	564,433	597,322
		564,433	597,322

				FOR THE YEAR ENDED 31MARCH 2022
					2022	2021
Creditors:		amounts	falling due in more than one year (continued)		f	f
Loans
An analysis ofthe			maturity	of loans is given below:
Amounts		falling due within one year or on demand:
Bank	loans				30,930	28,897
					30,930	28,897
Amounts		falling due between		one and two years:
Bank	loans				30,930	28,897
					30,930	28,897
Amounts		falling due between		two and five years:
Bank	Ioa	ns			92,789	86,691
					92,789	86,691
Amounts		falling due after five years:
Bank	loans				440,714	481,734
					440,714	481,734
					595,363	626,219

At 31 March 2022 the charity had minimum lease follows:	payments under non-cancellable operati	ng leases a
	2022	2021
	f	f
Expiry date:
Within 1year	6,336	24,531
Between 1and 5years	5,397	6,442
Over 5years	144
	11,877	30,973

At 31 March 2022 the charity had minimum lease follows:	receipts due under non-cancellable opera	ting leases a
	2022	2021
	f	f
Expiry date:
Within 1year	68,500	137,000
Between 1and 5years		68,500
	68,500	205,500

scheme providers tota	scheme providers tota	scheme providers tota	scheme providers tota	lling	f20,895(2021	:f18,212).
19 Analysis ofcharitable				funds
					At 1				At 31
					April	Income	Expenditure	Transfers	March
					2021 f	and gains f	and losses f	f	2022 f
Analysis of movements			in
unrestricted funds:
General reserve
General					3,260,186	7,397,896	(7,426,109)	(266,749)	2,965,224
Fair value reserve					700,000				700,000
Total General reserve					3,960,186	7,397,896	(7,426,109)	(266,749)	3,665,224
Designated reserve
Fixed asset fund					3,191,695		(325,791)	266,749	3,132,653
Unrestricted funds					7,151,881	7,397,896	(7,751,900)		6,797,877
Analysis ofmovements			in
restricted funds:
Restricted revenue	funds
Nurses' social committee			fund		3,274				3,274
Helen Ley physio equipment					4,241				4,241
New build professional		fees			13,670				13,670
Software fund					1,543				1,543
Leisure and sporting	activities				1,972				1,972
Other					4,808				4,808
					29,508				29,508
Restricted capital funds
New build fund					25				25
New ensuite room					45,500				45,500
					75,033				75,033
Endowment fund (RMCHD)					4,250,000				4,250,000
Total funds					11,476,914	7,397,896	(7,751,900)		11,122,910

		Tangible		Net	Long
		fixed		current	term
		assets	Investments	assets	creditors	Total
		f	f	f	f	f
Unrestricted	funds
General reserve			3,106,778	558,446		3,665,224
Designated	reserve	3,728,016		(30,930)	(564,433)	3,132,653
Restricted funds				75,033		75,033
Endowment	fund	4,250,000				4,250,000
		7,978,016	3,106,778	602,549	(564,433)	11,122,910